Loading...
•
Jun 30, 2022
Cerus Q2 2022 Earnings Report
Cerus's Q2 2022 results showed record product revenue and a 26% year-over-year increase in total revenue.
Key Takeaways
Cerus Corporation announced record product revenue for the second quarter of 2022, with total revenue reaching $47.6 million, a 26% increase year-over-year. The company reiterated its full-year 2022 product revenue guidance of $160-165 million.
Total revenue for Q2 2022 was $47.6 million, a 26% increase year-over-year.
Product revenue for Q2 2022 was $41.0 million, a 30% increase year-over-year.
Net loss attributable to Cerus Corporation for Q2 2022 was $8.4 million, or $0.05 per share.
The company reiterated its full-year 2022 product revenue guidance of $160-165 million.
Revenue by Segment
Revenue by Geographic Location
Forward Guidance
The Company expects full-year 2022 product revenue will be in the range of $160-165 million, representing strong growth of approximately 22%-26% compared to full-year 2021 product revenue of $130.9 million.
Positive Outlook
- Reiterating full-year 2022 product revenue guidance range of $160-165 million.
- Strong underlying demand for products.
- Growth opportunities expected to offset foreign exchange headwinds.
- Continued financial discipline.
- Well positioned and securely capitalized to achieve cashflow breakeven.
Challenges Ahead
- Significant macroeconomic issues challenging various aspects of the global economy.
- Expected persistence of foreign exchange headwinds.
- Uncertainty of future capital requirements.
- Risks associated with commercialization and market acceptance of the INTERCEPT Blood System.
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...